Expression Analysis of Fibronectin Type III Domain-Containing (FNDC) Genes in Inflammatory Bowel Disease and Colorectal Cancer
Table 2
CRC patients’ characteristics.
Number of subjects
10
Age, median years (range)
64.5 (50-80)
Age at first diagnosis ()
Sex (male/female)
10/0
Localization
Ileum
0
Caecum
0
Ascending colon
1
Transverse colon
1
Descending colon
1
Sigmoid colon
2
Rectum
6
Neoadjuvant therapy
None
8
Grade 1 (Dworak)
1
Grade 2 (Dworak)
1
UICC stage
NA
1
Stage I
4
Stage II
3
Stage III
1
Stage IV
1
Histological differentiation
NA
1
G1
0
G2
8
G3
1
G4
0
Microsatellite stability
NA
2
MSS
8
MSI
0
KRAS mutation
1
BRAF mutation
1
Positive family history
5
Smokers (pack-years, range)
7 (28, 10-75)
Daily alcohol
5
Laboratory findings ()
Erythrocytes (1012/L)
Leukocytes (109/L)
Thrombocytes (109/L)
Hemoglobin (g/dL)
Sodium (mmol/L)
Potassium (mmol/L)
CEA (μg/L)
CA 19-9 (U/mL)
The column lists characteristics for all patients with CRC. Abbreviations: UICC: Union for International Cancer Control; NA: not available; G1: well differentiated; G2: moderately differentiated; G3: poorly differentiated; G4: undifferentiated; CEA: carcinoembryonic antigen; CA 19-9: carbohydrate antigen 19-9.
